Consistently, immunoblot analysis also demonstrated downregulated Shp2 expression in ESCC tissues relative to adjacent normal tissue (0.50 ± 0.21-folds, p = 0.019; Figure 1C). This evidence concerns the gene PTPN11 and esophageal squamous cell carcinoma.